Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review.
Saved in:
| Title: | Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review. |
|---|---|
| Authors: | Kumar S; Mayo Clinic, Rochester, MN. Electronic address: Kumar.Shaji@mayo.edu., Leleu X; Poitiers University Hospital, Poitiers, France., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Popat R; University College London Hospitals NHS Foundation Trust, London, UK., Suero B; EVERSANA, Burlington, ON, Canada., Craigie S; EVERSANA, Burlington, ON, Canada., Spin P; EVERSANA, Burlington, ON, Canada., Patel L; EVERSANA, Burlington, ON, Canada., Ramirez AO; EVERSANA, Burlington, ON, Canada., Hampp C; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Ge W; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Ma Q; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Jagannath S; Mount Sinai Hospital, New York City, NY. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 Oct; Vol. 25 (10), pp. 730-738.e11. Date of Electronic Publication: 2025 Apr 03. |
| Publication Type: | Journal Article; Systematic Review; Consensus Statement |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40410023 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink>; Mayo Clinic, Rochester, MN. Electronic address: Kumar.Shaji@mayo.edu.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Poitiers University Hospital, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Popat+R%22">Popat R</searchLink>; University College London Hospitals NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Suero+B%22">Suero B</searchLink>; EVERSANA, Burlington, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Craigie+S%22">Craigie S</searchLink>; EVERSANA, Burlington, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Spin+P%22">Spin P</searchLink>; EVERSANA, Burlington, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Patel+L%22">Patel L</searchLink>; EVERSANA, Burlington, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Ramirez+AO%22">Ramirez AO</searchLink>; EVERSANA, Burlington, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Hampp+C%22">Hampp C</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Ge+W%22">Ge W</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Ma+Q%22">Ma Q</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Jagannath+S%22">Jagannath S</searchLink>; Mount Sinai Hospital, New York City, NY. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2025 Oct; Vol. 25 (10), pp. 730-738.e11. <i>Date of Electronic Publication: </i>2025 Apr 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Systematic Review; Consensus Statement – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40410023 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2025.03.013 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 730 Titles: – TitleFull: Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kumar S – PersonEntity: Name: NameFull: Leleu X – PersonEntity: Name: NameFull: Weisel KC – PersonEntity: Name: NameFull: Popat R – PersonEntity: Name: NameFull: Suero B – PersonEntity: Name: NameFull: Craigie S – PersonEntity: Name: NameFull: Spin P – PersonEntity: Name: NameFull: Patel L – PersonEntity: Name: NameFull: Ramirez AO – PersonEntity: Name: NameFull: Hampp C – PersonEntity: Name: NameFull: Ge W – PersonEntity: Name: NameFull: Ma Q – PersonEntity: Name: NameFull: Jagannath S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 25 – Type: issue Value: 10 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |
